Ausgabe 3/2015
Inhalt (10 Artikel)
Interethnic Differences in Pharmacokinetics of Antibacterials
Danny Tsai, Janattul-Ain Jamal, Joshua S. Davis, Jeffrey Lipman, Jason A. Roberts
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Nebulized Sodium Nitrite (AIR001) Following Repeat-Dose Inhalation in Healthy Subjects
Peter J. Rix, Andrew Vick, Neil J. Attkins, Geoffrey E. Barker, Adrian W. Bott, Harry Alcorn Jr., Mark T. Gladwin, Sruti Shiva, Stephen Bradley, Azra Hussaini, William L. Hoye, Ed L. Parsley, Hiroko Masamune
Efficacy of Tolvaptan Added to Furosemide in Heart Failure Patients with Advanced Kidney Dysfunction: A Pharmacokinetic and Pharmacodynamic Study
Keisuke Kida, Yugo Shibagaki, Naoto Tominaga, Naoki Matsumoto, Yoshihiro J. Akashi, Fumihiko Miyake, Kenjiro Kimura
Population Pharmacokinetic Analysis of Tesamorelin in HIV-Infected Patients and Healthy Subjects
Mario González-Sales, Olivier Barrière, Pierre Olivier Tremblay, Fahima Nekka, Jean-Claude Mamputu, Sylvie Boudreault, Mario Tanguay
Application of Modeling and Simulation to a Long-Term Clinical Trial: A Direct Comparison of Simulated Data and Data Actually Observed in Japanese Osteoporosis Patients Following 3-Year Ibandronate Treatment
Kiyohiko Nakai, Satofumi Iida, Masato Tobinai, Junko Hashimoto, Takehiko Kawanishi
A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation
Junjie Ding, Yi Wang, Weiwei Lin, Changlian Wang, Limei Zhao, Xingang Li, Zhigang Zhao, Liyan Miao, Zheng Jiao
Quantitative Methods for Prediction of the Effect of Cytochrome P450 Gene Polymorphisms on Substrate Drug Exposure
Sylvain Goutelle, Michel Tod
Quantitative Methods for Prediction of the Effect of Cytochrome P450 Gene Polymorphisms on Substrate Drug Exposure: Authors’ Reply
Jonatan D. Lindh, Ming Chang, Gunnel Tybring, Marja-Liisa Dahl